Goldman Sachs Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces Price Target of $32
Portfolio Pulse from richadhand@benzinga.com
Goldman Sachs analyst Corinne Jenkins initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and announces a price target of $32.
May 24, 2023 | 9:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs initiates coverage on IDEAYA Biosciences with a Buy rating and a price target of $32.
Goldman Sachs, a highly influential investment bank, has initiated coverage on IDEAYA Biosciences with a Buy rating and a price target of $32. This positive rating from a reputable analyst is likely to boost investor confidence in IDYA and drive its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100